Physician profile
Uel Dean Hansen
NPI 1538215447
$11,847.44
in general payments reported to CMS, 2019-2025
6 companies · $2,405 in 2025
The $2,405 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.85 · 2021: $61.05 · 2022: $1,263 · 2023: $1,616 · 2024: $6,450 · 2025: $2,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,672 · Food and Beverage: $2,615 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,671.65 |
| Food and Beverage | $2,614.95 |
| Education | $184.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,880.64 | 2021-2025 | Mako, Insignia, Triathlon |
| Pacira Pharmaceuticals Incorporated | $2,626.41 | 2022-2023 | Iovera, Zilretta |
| Zimmer Biomet Holdings, INC. | $200.78 | 2023 | Persona, Osseoti Reconstructive System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.85 | 2020 | |
| Siemens Medical Solutions USA, INC. | $51.66 | 2022 | |
| Depuy Synthes Sales INC. | $35.10 | 2024-2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uel Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.